REGENXBIO INC

RGNX NASDAQ

pantheo

Failed breakdown in weekly so far

RocketTickers

RGNX: REGENXBIO Inc. 2020-08-25 07:00:00 REGENXBIO Announces FDA Clearance of IND for Phase II Trial of RGX-314 for the Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery

SatSeh

I strongly believe this is going higher - has cash and have good enough catalyst for 2H, 2020 for it to run up. Good luck

Dilloo22

Broke its downtrend, looks like a decent retest of the uptrend.

st0nkz

wuz like watching the grass grow.

st0nkz

fckn finally

MS_Money_Moves

RGNX sold off 12% today on news of a partial clinical hold on an NVS gene therapy trial using its vector. After reading the press release I think this was an overreaction and the stock price will bounce back swiftly into RGNX earnings catalyst on 11/08/2019. It is sold off right to the bottom of its channel making for a beautiful setup!

st0nkz

biotechhhhhfhshefslkjhflkjsesixldv

st0nkz

once again i have no idea what i'm doing.

st0nkz

.

st0nkz

.

follow_the_money

This year has been full of positive catalysts for RGNX. As RGNX continues to build out their clinical pipeline, data catalyst from upcoming phase 2a report on their Wet-AMD gene therapy product could send the stock roaring higher. RGNX is set to report data Oct. 13, 2019 and the companies technical setup is quite nice. The Wet-AMD market is a lucrative opportunity...

GioBru

The prices are around the 200 weekly SMA. From thet level is possible a bound.

lentiv

Catalyst: possible buyout.

09:14

follow_the_money

RGNX and Novartis just received FDA approval of Gene Therapy treatment for Spinal Muscular Atrophy (SMA). (SMA)Spinal Muscular Atrophy is a disease affecting the motor nerve cells in the spinal cord, taking away the ability to walk, eat, or breathe. It is the number one genetic cause of death for infants. According to a company filling, price tag for...

iamdeepak

I would take SL as 45.5 if you go big or SL as 42 if you can bear the loss on small size.

UnknownUnicorn461520

Some potential profit targets and short entries listed above. Short targets listed below.

EmileLetellier

This stock has been following a channel up pattern and it seems very steady. I would buy at the intersection between the 14,48 fibonacci retracement level and the trendline i drew on the chart.